Home > EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids. (19 Dec 2022)

External website: https://www.emcdda.europa.eu/news/2022/emcdda-tech...


On 16 December, the EMCDDA held the first ‘Technical expert meeting on hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSCs)’ as part of its ongoing work to support EU and national preparedness and response to emerging NPS risks. Hexahydrocannabinol is the first semi-synthetic cannabinoid reported in the EU and has been monitored as a NPS by the EU Early Warning System since 21 October 2022. Unlike synthetic cannabinoid receptor agonists found in Spice-type products, HHC can be made from cannabidiol extracted from low-THC cannabis (hemp).

The meeting brought together over 140 experts from the Reitox national focal points, EU Early Warning System network, law enforcement and forensic and customs laboratories. The purpose of the event was to exchange information on the HHC situation at EU and national level and to analyse, assess and discuss available information and how to fill knowledge gaps. 

The following topics were covered at the meeting: chemistry, analysis, pharmacology, behavioural effects and the toxicology of HHC and related cannabinoids; and HHC at EU and national level. It also looked at the United States Farm Bill (1) and legalisation of hemp, and the proliferation of semi-synthetic cannabinoids in the US....

Item Type
News
Publication Type
International
Drug Type
Cannabis, New psychoactive substance
Intervention Type
Screening / Assessment
Source
Date
19 December 2022
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
EndNote

Repository Staff Only: item control page